Key statistics
On Thursday, Arcus Biosciences Inc (RCUS:NYQ) closed at 16.80, -18.45% below its 52-week high of 20.60, set on Sep 20, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 17.04 |
---|---|
High | 17.31 |
Low | 16.64 |
Bid | 13.00 |
Offer | 18.72 |
Previous close | 16.49 |
Average volume | 515.84k |
---|---|
Shares outstanding | 91.43m |
Free float | 54.27m |
P/E (TTM) | -- |
Market cap | 1.54bn USD |
EPS (TTM) | -3.10 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 00:00 BST.
More ▼
- Arcus Biosciences Announces New Employment Inducement Grants
- Arcus Biosciences Secures Up to $250 Million Term Loan Facility from Hercules Capital
- Arcus Biosciences to Participate in Two Upcoming Investor Conferences
- Arcus Biosciences Reports Second-Quarter 2024 Financial Results and Provides a Pipeline Update
- Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2024 Financial Results and Pipeline Update
- Taiho Pharmaceutical Exercises Option for an Exclusive License to Quemliclustat in Japan and Certain Territories in Asia
More ▼